Posted by: ctraderd | June 26, 2012

HZNP Soars After Teaming Up With Covidien

On June 18, Mallinckrodt, or Covidien Pharmaceuticals (COV), teamed up with Horizon Pharmaceuticals (HZNP). As part of the agreement, Mallinckrodt will promote DUEXIS, which is ibuprofen and famotidine, through December 14, 2014. DUEXIS is a drug made by Horizon Pharmaceuticals (HZNP) that was approved in August 2011. DUEXIS helps with gastrointestinal problems and it works well according to the FDA trials on the drug last year.

Since Horizon Pharmaceuticals has teamed up with Covidien Pharmaceuticals, Horizon’s stock price has gone up +1.44 or +30.23%.



Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s


%d bloggers like this: